Ebola

The 2024 Center for Structural Biology Symposium, which took place on March 28, celebrated its decades of success, research undertakings, and goal of strengthening the structural biology community at Vanderbilt. Read More

A combination of two broadly acting monoclonal antibodies isolated by researchers at Vanderbilt University Medical Center protected non-human primates from ebolavirus disease, which causes severe and often-fatal hemorrhagic fever in humans. Their findings, published this week in the journal Cell, bring closer to development the first clinical therapy effective… Read More